Skip to main content
Free shipping on all orders
888-559-3802
VitabaseIngredients

Nopal

Health Conditions22
Table of contents

Other Names

Barbary figCactus chinensis Roxb.Cactus compressus Salisb.Cactus ficus Thunb.Cactus ficus-indicaCactus ficus-indica L.Cactus opuntia Guss.Cactus opuntia L.Cactus pearChardon d'IndeChumberaFichi d'IndiaFico d'IndiaFicuriniaFiga de moroFigo da IndiaFigo de cactoFigo de pitoiraFigo tunoFigos da IndiaFigue de BarbarieFigue de cactusFigueira da BarbáriaFigueira da IndiaFiguier d'IndeFiguier de BarbarieFigumoriscaFrangosykaHigo chumboHigos chumbosIndian figIndian fig opuntiaMission cactusMission prickly pearNohpalliNopal de CastillaNopal pelónNopalesNopalitosOpuntiaOpuntia amyclaeaOpuntia apurimacensis (F.Ritter) R.Crook & MottramOpuntia arcei CárdenasOpuntia castillae GriffithsOpuntia cordobensis Speg.Opuntia ficus-barbarica A.BergerOpuntia ficus-indicaOpuntia ficus-indica (L.) Mill.Opuntia fusicaulis GriffithsOpuntia gymnocarpa WeberOpuntia incarnadilla GriffithsOpuntia joconostle F.A.C.Weber ex DiguetOpuntia leiascheinvariana Martínez-Gonz. & GallegosOpuntia leucostata J.ForbesOpuntia leucosticta H.L.Wendl. ex Pfeiff.Opuntia maxima Mill.Opuntia megacantha Salm-DyckOpuntia mexicana Pfeiff.Opuntia obovata GriffithsOpuntia opuntia (L.) H.Karst.Opuntia paraguayensis K.Schum.Opuntia tuna-blanca Speg.Opuntia vulgaris Mill.Palma-de-gadoPalma-gigantePaniniPavlosykaPencaPlatyopuntia apurimacensis F.RitterPlatyopuntia ficus-indica (L.) F.RitterPrickly pearPrickly pear cactusSabraSmooth mountain prickly pearSmooth prickly pearSpineless cactusSweet prickly pearTabaiboTuberous prickly pearTunaTuna cactusTuna de CastillaTuna de EspañaTuna españolaTuna mansa

Synopsis

Nopal (Opuntia ficus-indica): A Comprehensive Reference

1. Identity, Taxonomy, and Nomenclature

Opuntia ficus-indica, commonly referred to as prickly pear or nopal cactus, is a dicotyledonous angiosperm plant belonging to the Cactaceae family, characterized by its remarkable adaptation to arid and semi-arid climates in tropical and subtropical regions of the globe. The Cactaceae family, to which it belongs, comprises around 1,500 species of cactus.

Nopal is a common name in Spanish for Opuntia cacti (commonly referred to in English as prickly pear or tender cactus), as well as for its pads. The name nopal derives from the Nahuatl word nohpalli for the pads of the plant. The name means "tree that is of pads," derived from the plant's shape. The plant is also known by the common names Indian fig, Barbary pear, and cactus pear. Its binomial scientific name is Opuntia ficus-indica (L.) Mill., with Opuntia streptacantha being another species that has featured prominently in pharmacological research on nopal's traditional hypoglycemic effects.

There are about 114 known species in Mexico, where it is a common ingredient in numerous Mexican cuisine dishes. Farmed nopales are most often of the species Opuntia ficus-indica or Opuntia matudae, although the pads of almost all Opuntia species are edible. Originating from Mexico, it is now widespread through Central and South America, Australia, the Mediterranean basin and South Africa. After the Spanish conquerors brought the nopal cactus to Europe in the 16th century, it is also cultivated in Italy and other parts of the Mediterranean.

Plant Parts Used

Various parts of the plant, including cladodes, seeds, flowers, peels, and fruits, contribute to its therapeutic efficacy. The flat, photosynthetic stem segments known as cladodes (also called pads or pencas) constitute the primary form used medicinally and as a dietary supplement. Cladodes are rich in fibers such as pectin, lignin, cellulose, and hemicellulose and can be used as animal feed, fodder, or for human consumption. Flowers are normally used as infusions for their diuretic activity.

Common Forms and Preparations

  • Fresh cladodes (nopalitos): Young pads eaten raw or cooked as a vegetable. The nopal pads can be eaten raw or cooked, used in marmalades, soups, stews, and salads, as well as being used for traditional medicine or as fodder for animals.
  • Dried powder: Vacuum drying transforms fresh cladodes into powder that serves as a nutraceutical form for different clinical trials, and the vacuum drying process does not affect physicochemical and nutritional properties.
  • Capsules and tablets: Encapsulated dried nopal powder or standardized extracts are widely used in supplement research. Phytochemical and flavonoid content has been shown to decrease in tablets of commercial nopal due to the drying method.
  • Aqueous and alcoholic extracts: In traditional medicine, alcoholic extracts are indicated for anti-inflammatory, hypoglycemic, and antiviral purposes.
  • Fruit (tunas): Eaten raw, juiced, or processed into jams, jellies, and syrups.
  • Flowers: Used as infusions, particularly for diuretic effects in traditional medicine.

2. Traditional and Historical Use

Pre-Columbian Mesoamerica

The nopal (Spanish term, from nopalli in Nahuatl), or prickly pear cactus, has been a source of food for indigenous people across Mesoamerica since pre-Columbian times. Archaeological evidence points to the prevalence of nopal in pre-Columbian diets as early as 9,000 years ago. It is believed to be one of the first plants to be domesticated in Mesoamerica.

The cactus was more than just another food source for Mexico's indigenous ancestors. Nopal was imbued with deep symbolic significance and was regarded by pre-Columbian societies as sacred — the plant is a prominent feature across ancient codices, glyphs, and stone carvings. The Aztec capital was named Tenochtitlán, a Nahuatl name which translates roughly to "the place where nopal cactus grows from a stone."

Aztec Medicinal Use

In ancient times, Aztecs used the juice of the nopal to treat burns and skin conditions. It was ground or juiced up in poultices and healing treatments. Indigenous peoples across Mesoamerica used both the pads (nopales) and the fruit (tunas) for food, medicine, and cultural practices like ritual offerings.

Broad Traditional Medicinal Applications

In traditional medicine, Opuntia ficus-indica has been used for the treatment of burns, wounds, edema, hyperlipidemia, obesity, and catarrhal gastritis. Tender cladodes have been used in traditional Mesoamerican medicine to treat several conditions, such as asthma, cancer, diabetes, gastric mucosa diseases, heart conditions, hypercholesterolemia, hypertension, obesity, and rheumatic pain.

Sub-Saharan and North African Traditional Use

In the sub-Saharan traditional medicine pharmacopeia, cactus flowers and fruits are given as anti-ulcerogenic or antidiarrheal agents; flowers are also administered as an oral anti-hemorrhoid medication, and cladode sap as a treatment for whooping cough. Since pre-Hispanic times, numerous species of Cactaceae are used by indigenous communities of mountain regions as sources of food, medicine, dyes, fodder, and materials for construction.

3. Key Constituents and Active Compounds

The plant's rich composition in polyphenols, vitamins, polyunsaturated fatty acids, and amino acids has been highlighted through the use of a large panel of extraction methods. The different plant parts — cladodes, fruit pulp, seeds, flowers, and peel — vary significantly in their phytochemical profiles.

Dietary Fiber and Polysaccharides

One of the main constituents of cladodes is dietary fiber, a class of compounds characterized by a mixture of polymeric carbohydrates of vegetable nature, and oligosaccharides or polysaccharides, such as cellulose, hemicellulose, pectic substances, or resistant starch, which may be associated with lignin and other components such as polyphenols, waxes, saponins, cutin, phytates, or proteins.

Total dietary fiber is classified according to its solubility in water into two fractions: soluble dietary fiber (SDF) and insoluble dietary fiber (IDF). The SDF is composed of mucilage, gums, pectins, and some hemicelluloses, and is associated with the reduction of cholesterol levels and the control of the absorption of glucose.

Mucilage, the main component of cladodes, is a hydrophilic arabinogalactan-type polysaccharide of high molecular weight, combined with proteins and minerals. Particularly important is the presence of β-polysaccharides (glucose units connected by (1→4)-β bonds connected with (1→3)-β-bonds), characterized by an irregular structure that leads to a water-soluble structure. This type of water-soluble fiber is capable of absorbing large quantities of water and leads to the formation of viscous and gelatinous colloids which improve the absorption of many organic molecules.

Polysaccharides are abundant in cladode extracts and are endowed with antidiabetic and antiglycation effects.

Betalains

Prickly pears are rich in phenols, flavonoids, betaxanthins, and betacyanins, which favor a healthy status through hypoglycaemic and hypolipidemic actions, and antioxidant properties. Remarkably, among existing natural pigments, betalains are present at high amounts in cactus. Certain water-soluble nitrogenous Opuntia phytochemical compounds/pigments known as betalains are classified as betacyanins (red to purple coloured) and betaxanthins (yellow and orange coloured). The primary betalain constituents are betanin (a betacyanin) and indicaxanthin (a betaxanthin), which have been specifically identified in fruit and cladodes and are associated with potent antioxidant activity.

Flavonoids and Phenolic Acids

Opuntia ficus-indica and other species also contain an array of flavonoid compounds, most notably kaempferol and quercetin. Cladodes also represent a source of phytochemicals, such as phenolic acids (aromadendrin, taxifolin or dihydroquercetin, isorhamnetin, vitexin, kaempferol, quercetin, betalains, betacyanins, rutin, and isorhamnetin) and flavonoids, and they contain citric and malic acids and some glucose and fructose. Catechin, quercetin, kaempferol, isorhamnetin, and chlorogenic, ferulic, and p-coumaric acid have been identified in cladode extracts by HPLC analysis. The major phenolic compounds identified in cladode hydroalcoholic extract include isorhamnetin derivatives and phenolic acids, including piscidic and eucomic acids.

Vitamins, Minerals, and Fatty Acids

The nutritional value of cactus pear fruit mainly rests on its content in ascorbic acid, vitamin E, carotenoids, fibers, amino acids, and on large amounts of glucose and fructose. Opuntia ficus-indica fruit is plentiful with the amino acid taurine, a therapeutic compound, alongside vitamins C, E, and K. Regarding the mineral content of Opuntia ficus-indica, values obtained per 100 g include 63.4 mg Mg; 18.7 mg Na; 108.8 mg K; 316.5 mg Ca; 37.8 mg Mn; 25.9 mg Fe; 12.6 mg Zn. Potassium (K) and calcium (Ca) are the most abundant minerals in cladodes.

Alkaloids and Other Minor Constituents

Alkaloids, indicaxanthin, neobetanin, and various flavonoids have been isolated from the cactus. Phytochemical groups such as phenolic acids, sterols, esters, coumarins, terpenoids, and alkaloids bring about several health benefits including hypoglycaemic and antioxidant activities.

4. Established and Proposed Mechanisms of Action

Glycemic Regulation

Some studies indicate that certain cactus constituents, such as flavonoids, may inhibit intestinal α-glucosidase activity, thereby delaying carbohydrate digestion and absorption. Other research suggests they may reduce endogenous glucose output by modulating the activity of key hepatic gluconeogenic enzymes. At the molecular level, studies suggest that cactus bioactive compounds can promote GLUT4 translocation and enhance insulin signaling through pathways such as AMPK, PI3K/Akt, and MAPK. They may also modulate gut microbiota and short-chain fatty acid (SCFA) metabolism, indirectly improving glucose homeostasis.

The soluble dietary fiber fraction — composed of mucilage, gums, pectins, and some hemicelluloses — is associated with the control of the absorption of glucose. The high viscosity of mucilage polysaccharides in the gastrointestinal lumen is thought to slow gastric emptying and reduce the rate of glucose absorption, contributing to reduced postprandial glycemic excursions.

Antioxidant Activity

Opuntia ficus-indica is known for its high content in polyphenols exhibiting antioxidant and anti-inflammatory properties. The phenolic compounds are important antioxidants since phenoxy radical intermediates are relatively stable due to resonance and act as terminators of propagation route by reacting with other free radicals. The antioxidant properties of betalain pigments represent an additional argument in favor of the development of their use in nutrition and health.

Anti-inflammatory Activity

The identified natural cactus compounds and derivatives were shown to be endowed with biologically relevant activities including anti-inflammatory, antioxidant, hypoglycemic, antimicrobial, and neuroprotective properties. The cause of severity of the alcohol hangover can be, at least in part, inflammation and disruption of lipid metabolism homeostasis, and nopal's anti-inflammatory properties have been proposed to underlie its observed effects in that context.

Lipid Metabolism

The cladodes contain high quantities of fiber, including mucilage, pectin, lignin, cellulose, and hemicellulose — substances that can bring well-being to the metabolism of lipids and sugars. Soluble fibers such as pectin and mucilage are thought to bind bile acids in the intestine, increasing their fecal excretion and thereby compelling the liver to synthesize new bile acids from cholesterol, which lowers circulating LDL cholesterol.

Gastric Cytoprotection

The pectin polysaccharides from O. ficus-indica cladodes probably may affect gastrointestinal mucosa regeneration. O. ficus-indica cladodes give rise to cytoprotection phenomena by breaking up the epithelial cells and stimulating an increase in mucus production in ethanol-induced ulcer, and preventive treatment with O. ficus-indica cladodes can stop the ulcerogenic agent from preventing damage.

Gut Microbiota Modulation

Cactus bioactive compounds may modulate gut microbiota and short-chain fatty acid (SCFA) metabolism, indirectly improving glucose homeostasis. Preclinical evidence indicates that gut microbiota analysis showed significant differences in β-diversity, along with increased α-diversity and higher abundance of Lachnospiraceae, following cactus intake in animal models, suggesting a prebiotic-like function of nopal's fiber components.

5. Scientific Evidence by Area of Health

5.1 Blood Glucose Management and Type 2 Diabetes

Overview: This is the most studied health application of nopal. Evidence comes from multiple human clinical trials and systematic reviews, though the overall body of evidence remains preliminary and limited by small sample sizes, short durations, and heterogeneous preparations.

Systematic reviews: A systematic review analyzing 20 human studies on Opuntia's effects on blood glucose and insulin levels indicated that Opuntia leaves and certain Opuntia products significantly reduced blood glucose and insulin, suggesting its potential as an antidiabetic adjuvant. However, the quality of evidence appeared to vary based on the type of Opuntia product used. Studies that used specifically the fruit or cladode had high risk of bias, whereas studies that used combined Opuntia products had a lower risk of bias. Numerous mechanisms of action were proposed where positive findings were reported, with emphasis on dualistic glucose-dependent and independent actions; however, mechanisms require further elucidation.

Key individual trials:

  • Several randomized controlled and crossover trials have consistently reported that the ingestion of Opuntia ficus-indica cladodes (nopal) reduces postprandial glycemic excursions in patients with type 2 diabetes. For instance, Bacardí-Gascón et al. demonstrated that adding steamed nopal to a traditional Mexican breakfast significantly attenuated postprandial glucose area under the curve (AUC) without altering fasting glucose.
  • One trial investigated the glycemic responses to consumption of cladode powder (50 g) in healthy participants. The powder significantly lowered serum glucose (p < 0.001) and produced a glycemic index score of 32.5 ± 4.0, and insulinemic index of 36.1 ± 6.1, upon ingestion.
  • In the same study's second experiment, the effect of cladode consumption in combination with various breakfasts on serum glucose and insulin in type 2 diabetes (n = 14) and healthy participants (n = 7) was investigated. The results showed that type 2 diabetes participants' nopal consumption in combination with a high carbohydrate breakfast incurred significant decreases in serum glucose (30 min, 45 min and 1 h; p < 0.01) and glucose by area under the curve (AUC reduction 287 ± 30 mmol/L; p < 0.001), with no significant differences reported in serum insulin.
  • A crossover and single-blinded study gave 30 capsules containing dried nopal to 10 diabetic subjects in fasting condition and measured serum glucose throughout 3 hours. Opuntia capsules did not show an acute hypoglycemic effect and did not influence OGTT. In diabetic patients, serum glucose, cholesterol, and triglyceride levels did not change with Opuntia, but they increased with placebo (p < 0.01 for glucose and cholesterol).
  • To assess if a dehydrated extract of nopal stems retains the glycemic effect of the entire stems, six patients with type II diabetes received 30 capsules containing 10.1 ± 0.3 g of extract. Nopal extract did not reduce fasting glycemia in diabetic subjects; nevertheless, the extract diminished the increase of serum glucose following a dextrose load. Peak serum glucose was 20.3 ± 18.2 mg/dl lower in the nopal test than in the control (p < 0.025).
  • A dose-finding study using a proprietary extract (OpunDia™) in pre-diabetic participants found evidence of acute blood glucose lowering effects. This study showed the acute blood glucose lowering effects and the long-term safety of the proprietary product OpunDia, supporting the traditional use of Opuntia ficus-indica for blood glucose management.

Evidence strength: Preliminary to moderate. Human trials generally support a postprandial glucose-lowering effect of whole or powdered cladodes, especially when consumed with high-carbohydrate meals. Effects on fasting glucose are less consistent. Some preliminary evidence shows that prickly pear cactus can decrease blood sugar levels in people with type 2 diabetes. Limitations include small sample sizes, methodological heterogeneity, variable Opuntia preparations (species, plant part, processing method), and short durations.

5.2 Lipid Profile and Cardiovascular Risk

Overview: Clinical evidence for nopal's effects on lipids is mixed. Several trials report favorable changes, while others find no significant effect.

  • The effects of insoluble fiber-rich powder from highly mature Opuntia ficus-indica cladodes on lipid parameters in overweight or obese adults with dyslipidemia were assessed in a randomized controlled trial. Thirty-five participants received 5 g/day or 15 g/day of nopal powder combined with dietary counseling, or dietary counseling alone, for 12 weeks. Dietary guidance aimed to achieve approximately 30 g/day total fiber intake. The nopal powder contained 49.5% total dietary fiber, predominantly insoluble. Within-group analyses showed significant reductions in total cholesterol and LDL cholesterol in both supplemented groups, while HDL cholesterol increased in all groups.
  • A systematic review of 11 trials of prickly pear fruit vs. cladode in healthy, obese, or metabolically impaired subjects found 5 studies reporting significant reductions in the levels of total cholesterol following consumption of the fruit, whereas consumption of cladodes appeared to decrease the levels of LDL cholesterol, with 1 study reporting additional increases in plasma HDL cholesterol in subjects older than 45.
  • A meta-analysis of 5 randomized clinical trials of Opuntia ficus-indica reported significant reductions in body mass index, percentage body fat, systolic and diastolic blood pressures, and total cholesterol levels but no significant difference in body weight between treatment and control groups.
  • One intervention study (n=39 volunteers, aged 19–69 years) with at least two components of metabolic syndrome found that the Opuntia ficus-indica-treated group experienced: a mitigation in serum glucose and insulin (−29% and −64%, respectively); decreased glycated hemoglobin (−31%) and HOMA-IR (−41%); a reduction in serum total cholesterol (−21%); and serum triglycerides and VLDL-triglycerides decreased by 35% and 20%, respectively.
  • In contrast, one study found that both cucumber and nopal significantly increased plasma triglyceride levels with no significant difference in oxidative stress markers and lipoprotein subfractions, leading authors to conclude that the potential of Opuntia ficus-indica cladodes to improve cardiometabolic risk and oxidative stress biomarkers cannot be asserted in patients with hypercholesterolemia.

Evidence strength: Preliminary and inconsistent. Some positive signals exist for reductions in LDL cholesterol and triglycerides, particularly in metabolically compromised populations, but trial quality is variable and results are not uniformly positive across study designs.

5.3 Obesity and Body Weight

In humans suffering from metabolic syndrome, nopal reduced blood level of triglycerides and glucose, but not of cholesterol. It slightly reduced waist circumference, but not body weight and body mass index. Although the studies of Opuntia's influence on markers of obesity generated variable and sometimes contradictory results, the majority of available reports suggest that nopal cactus extract can down-regulate fat storage. Animal experiments demonstrated its ability to decrease plasma levels of total and LDL cholesterol and triglycerides and to reduce fat accumulation and body mass.

A systematic review and meta-analysis of 15 controlled studies (N=1670) on the effects of Mexican ancestral food consumption on obese patients reported significant reductions in body mass index, as well as differences in body weight, waist circumference, total cholesterol, and triglycerides following ingestion of nopal (Opuntia ficus-indica), cocoa, avocado, or common bean.

Evidence strength: Weak to preliminary in humans. Animal models show more consistent anti-obesity effects. Human evidence is limited primarily to reductions in waist circumference and certain metabolic markers rather than body weight per se.

5.4 Antioxidant Activity in Humans

One study evaluated the effectiveness of Opuntia ficus-indica supplementation in enhancing antioxidant levels. Fifty healthy participants, aged 18 years and older, received a daily supplement of 1500 mg for 3 months. These findings revealed a significant 48.1% increase in salivary total antioxidant capacity (TAC) (p < 0.001), indicating improved antioxidant activity. Simultaneously, oxidative stress biomarkers showed substantial reductions: malondialdehyde (MDA) decreased by 28.3%, nitrotyrosine (3-NT) decreased by 51.5%, and 8-hydroxy-2'-deoxyguanosine (8-OHdG) decreased by 59.8% (p < 0.001).

Evidence strength: Preliminary. This is a single small trial. The findings support the biological plausibility of antioxidant activity derived from the plant's phytochemical composition but require replication in larger, blinded, controlled trials.

5.5 Alcohol Hangover

In a double-blind, placebo-controlled, crossover trial (N=64), pretreatment with an extract of Opuntia ficus-indica significantly reduced nausea, dry mouth, and anorexia in healthy young adults — effects associated with inhibiting production of inflammatory mediators (Wiese et al., 2004, Archives of Internal Medicine). Several studies have evaluated the benefits of Opuntia ficus-indica against symptoms of alcohol hangover in humans. The cause of severity of the alcohol hangover can be, at least in part, inflammation and disruption of lipid metabolism homeostasis.

Evidence strength: Moderate for specific hangover symptoms (nausea, dry mouth, anorexia), based on a single reasonably well-designed RCT. Some research suggests that prickly pear cactus extract may lessen the unpleasant effects of a hangover, possibly due to its anti-inflammatory effects. The evidence does not support an effect on all hangover symptoms and has not been widely replicated.

5.6 Gastrointestinal Health and Irritable Bowel Syndrome

Clinical guidelines provide limited and conflicting recommendations regarding dietary fiber supplementation in irritable bowel syndrome (IBS). Nopal (Opuntia ficus-indica) is a cactus plant fiber containing both insoluble and soluble fibers that may have therapeutic potential in IBS. A 4-arm, double-blind, parallel, randomized controlled trial in 60 patients fulfilling Rome IV criteria for IBS was performed. Patients were randomized to receive either nopal fiber (10, 20, or 30 g/day) or placebo (30 g/day dextrose) for one week while keeping their usual diet. Nopal fiber supplementation at doses of 20 and 30 g/day was associated with short-term improvement in IBS symptoms, warranting a fully powered clinical trial of longer duration with symptomatic, physiological, and microbiological endpoints.

A systematic review of 10 randomized controlled trials of differing fiber supplements found that nopal fiber improved symptom severity in patients with functional bowel disorders.

Evidence strength: Preliminary. The IBS trial was short (one week), small (60 patients), and dose-response data are limited. The gastric cytoprotective effects demonstrated in animal models for peptic ulcer disease have not been adequately reproduced in human clinical trials.

5.7 Topical / Dermatological Applications

In a controlled study (N=42), a topical treatment containing xyloglucan, pea proteins, and Opuntia ficus-indica extract for 28 days significantly reduced disease severity, erythema, itching, induration, and scaling — similarly to calcipotriol/betamethasone — in patients with mild-to-moderate plaque psoriasis, with an excellent tolerability profile (Veraldi et al., 2024, Journal of Clinical and Aesthetic Dermatology). Traditional burn and wound applications reflect the historical use of cladode sap as a topical agent. However, nopal extract was only one component of the topical preparation studied, making it difficult to isolate the contribution of nopal alone.

Evidence strength: Very preliminary for topical dermatological use. Single controlled study in the context of a combination topical formulation.

5.8 Gut Microbiota Modulation

Preclinical work has explored nopal's potential as a prebiotic. In a mouse model, cactus supplementation reduced the body and liver weights elevated by the high-fat diet. Serum total cholesterol and free fatty acids were lowered and fecal cholesterol excretion was enhanced. Cactus consumption also elevated fecal total IgA and mucin contents. IL-4 expression in Peyer's patches was significantly increased. Gut microbiota analysis showed significant differences in β-diversity, along with increased α-diversity and higher abundance of Lachnospiraceae, following cactus intake. These are preclinical (animal) findings and have not been validated in human clinical trials.

6. Body Systems and Health Areas Associated with Nopal

  • Endocrine / Metabolic: Blood glucose regulation, insulin sensitivity, metabolic syndrome markers
  • Cardiovascular: LDL cholesterol, total cholesterol, triglycerides, blood pressure
  • Gastrointestinal: Gastric cytoprotection, bowel function, IBS symptom relief, prebiotic effects on gut microbiota
  • Antioxidant / Oxidative stress: Scavenging of reactive oxygen species through betalains, polyphenols, and vitamins C and E
  • Anti-inflammatory: Inhibition of pro-inflammatory mediators, relevant to hangover, metabolic inflammation, and skin conditions
  • Dermatological (topical): Wound healing, burn treatment (traditional), investigational use in plaque psoriasis
  • Body weight / Adipose tissue: Fat storage modulation (primarily shown in animal models)
  • Immune function: Investigated in animal models; human data lacking

7. Dosage Forms and Dosages Reported in Clinical Studies

Dosages vary substantially across studies depending on preparation type, plant species, plant part, and processing method. The following are dosages as reported in published sources cited in this article:

  • Nopal powder (cladode, dehydrated): Thirty-five participants were randomly assigned to receive 5 g/day or 15 g/day of nopal powder combined with dietary counseling for 12 weeks in a randomized controlled trial.
  • Nopal fiber powder (IBS trial): Patients received either nopal fiber (10, 20, or 30 g/day) or placebo for one week.
  • Dried nopal capsules: 30 capsules were given in fasting condition to 10 diabetic subjects in one trial; in a crossover and single-blinded study, 14 diabetic patients received 10 nopal capsules three times a day for 1 week.
  • Dehydrated extract capsules: Six patients with type II diabetes received 30 capsules containing 10.1 ± 0.3 g of extract.
  • Encapsulated aqueous extract (OpunDia™): Subjects received either 500, 1000, or 1500 mg of encapsulated Opuntia ficus-indica extract, or placebo capsules in a dose-finding crossover study.
  • Supplement capsules (antioxidant trial): Fifty healthy participants received a daily Opuntia ficus-indica supplement of 1500 mg for 3 months.
  • Nopal bone density trial: In a 24-week controlled study (N=69), daily consumption of 5 g of nopal (Opuntia ficus-indica) powder did not significantly affect bone mineral density, body mass index, fat percentage, or serum calcium levels in 40- to 60-year-old women compared to the control.

No universally established therapeutic dose exists for any indication. The dosages above reflect experimental conditions only. Phytochemical and flavonoid content has been shown to decrease in tablets of commercial nopal due to the drying method, highlighting that processing method may substantially alter the active compound content of any given commercial preparation.

8. Safety Considerations and Drug Interactions

General Tolerability

A meta-analysis of 5 randomized clinical trials of Opuntia ficus-indica reported significant reductions in several metabolic parameters. Adverse events included gastric intolerance and flu symptoms. As a food consumed in large amounts throughout Mexican and Mediterranean cultures for centuries, the nopal pad is eaten raw or cooked as a conventional food, and its general dietary safety profile at food doses is well established. Supplement preparations, which deliver concentrated extracts, present a different risk profile.

Hypoglycemia Risk from Drug-Herb Interactions

Regular nopal use could add to glucose-lowering effects of diabetes medications and raise hypoglycemia risk; allergic reactions and dermatitis from cactus contact are occasionally reported. Medscape's drug interaction database documents that Opuntia ficus-indica increases the effects of acarbose, glimepiride, glipizide, and glyburide by pharmacodynamic synergism, requiring caution and monitoring. A case report published in Annals of Pharmacotherapy (Sobieraj & Freyer, 2010) documented a probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes.

Cytochrome P450 Interactions

There may be examples where herbal medicines produce synergistic effects when used along with conventional medicines (e.g., nopal-hypoglycemic drugs). Research has also investigated nopal's effects on drug-metabolizing enzymes: one study found inhibitory and inductive effects of Opuntia ficus-indica extract and its flavonoid constituents on cytochrome P450s and UDP-glucuronosyltransferases (Jeong et al., 2018, International Journal of Molecular Sciences), which could potentially affect the metabolism of co-administered drugs, though the clinical significance of this has not been established in human pharmacokinetic studies.

Gastrointestinal Effects

Cladode seeds consumed in large amounts have been associated with intestinal obstruction. One case report (Kleiner et al., referenced in WebMD's professional monograph) described low colonic obstruction due to Opuntia ficus-indica seeds following consumption of large amounts of the fruit. High-fiber doses may cause bloating, flatulence, or loose stools, consistent with the effects of other high-fiber preparations.

Betalain Interference with Clinical Tests

The red betacyanin pigments (betanin) in nopal fruit are excreted in urine and can cause beeturia-like red discoloration of urine and stool, which may be mistaken for hematuria or rectal bleeding. This is a benign pharmacokinetic effect but has clinical diagnostic significance.

Pregnancy and Lactation

Herbal remedies are frequently used by pregnant women, but information about their safety during pregnancy and breast-feeding is scarce. No well-controlled human studies on nopal supplementation in pregnancy or lactation are currently available. Animal studies examining smooth-muscle effects have noted that cladode extracts caused uterine muscle relaxation in isolated tissue preparations, with addition of increasing concentrations of cladode extract causing uterine muscle relaxation. The clinical implications for human pregnancy remain uninvestigated.

Effect of Processing on Safety Profile

The effect of cooking versus raw nopal on bioactive component contents was evaluated. In general, a negative impact of temperature on bioactive components of the nopal was reported, suggesting that heavily processed or heat-dried commercial supplements may contain substantially altered phytochemical profiles compared to raw or minimally processed whole cladodes.

References

Health Conditions

Health conditions that Nopal may help support.

  • A double-blind RCT (N=60–67) found nopal fiber (20 g/day) significantly improved overall IBS symptom severity scores and gastrointestinal symptom rating scales in patients fulfilling Rome IV criteria for IBS, compared to placebo. The fiber's combined soluble and insoluble fractions are considered the active component. The trial duration was short (one week), and longer studies are needed.

  • Nopal cladodes are a rich source of polyphenols, betalains, carotenoids, ascorbic acid, and vitamin E, documented to enhance plasma antioxidant capacity in human studies. An extract of nopal cladodes was shown to enhance plasma antioxidant capacity in humans. Oven-dried cladode flour exhibits FRAP values up to 7.04 µmol TE/g, with high phenolic compound content. Both in vitro and in vivo evidence support meaningful antioxidant activity.

  • Nopal fiber's high soluble and insoluble fiber content promotes satiety and slows gastric emptying, which is biologically plausible for appetite suppression. A double-blind placebo-controlled crossover trial (N=64) showed nopal extract pretreatment significantly reduced anorexia (a surrogate for appetite dysregulation) associated with alcohol hangover. Human weight management trials have included appetite reduction as a proposed mechanism, and EBSCO documents human studies on appetite control.

  • Blood PressureScientific

    The 2015 Onakpoya et al. meta-analysis of RCTs found significant reductions in systolic and diastolic blood pressure with Opuntia ficus-indica supplementation in overweight/obese individuals. Animal and review studies also document hypotensive activity, attributed to polyphenols and betalains. Human evidence, while present, is largely derived from secondary outcomes in cardiometabolic trials.

  • Multiple small human trials and a systematic review indicate nopal (Opuntia ficus-indica) cladodes can meaningfully reduce postprandial blood glucose in people with type 2 diabetes. The effect is strongest for broiled nopal stems (500 g), producing approximately 17.6% reductions in serum glucose at 180 minutes. Capsule and juice forms have shown inconsistent results. Evidence is limited by small sample sizes and lack of large RCTs.

  • CholesterolScientific

    Several human RCTs and a systematic review/meta-analysis support nopal's ability to reduce LDL cholesterol and total cholesterol, and raise HDL, particularly in individuals with dyslipidemia or metabolic syndrome. A 6-week RCT (N=68) using NeOpuntia 1.6 g/meal significantly increased HDL and decreased LDL in women with metabolic syndrome. Effects are attributed primarily to soluble fiber content. Overall evidence is modest and results vary by formulation.

  • Nopal contains polyphenols, betalains, flavonoids, and omega-3 fatty acids documented to exert anti-inflammatory activity. Human trials show reductions in C-reactive protein with nopal-containing formulas in metabolic syndrome patients. In vitro and animal studies document suppression of TNF-α, IL-1β, and NF-κB pathways. A double-blind, placebo-controlled crossover trial (N=64) showed nopal extract significantly reduced markers of inflammation associated with alcohol hangover.

  • ConstipationScientific

    Nopal contains significant amounts of both soluble and insoluble dietary fiber documented to modulate stool frequency and consistency. IBS RCTs showed nopal fiber (20 g/day) normalized stool form in IBS patients. MRI studies have measured nopal fiber's effect on small intestinal water content and colonic volume, directly relevant to constipation relief. Traditional use for promoting bowel movements is extensive.

  • Human and animal studies demonstrate that nopal fiber modulates gut microbiota composition, increasing beneficial taxa and reducing markers of dysbiosis and metabolic endotoxemia. A 2022 human study in women with obesity found that dietary nopal intervention improved gut microbiota diversity. Animal studies show nopal reduces endotoxemia by modifying the cecal and colonic microbiota in high-fat-fed rats, increasing colonic occludin protein to reduce gut permeability.

  • Healthy WeightScientific

    Human clinical trials show nopal produces modest effects on body weight and BMI, generally within multi-ingredient protocols or calorie-restricted diets. A 2-month RCT demonstrated significant reductions in body weight, BMI, and waist circumference in metabolic syndrome subjects using a nopal-containing formula. Solo nopal supplementation has shown at most slight reductions in waist circumference without significant changes in body weight or BMI. Evidence for nopal alone as a weight-loss intervention remains weak.

  • Heart HealthScientific

    A meta-analysis of RCTs found that Opuntia ficus-indica supplementation produced significant reductions in both systolic and diastolic blood pressure, as well as improvements in cholesterol and triglycerides. These cardiovascular risk factor improvements are supported by multiple human trials. The polyphenol content of nopal is considered to contribute to vascular benefits. Evidence is moderate, primarily from short-term studies.

  • Human and animal evidence supports nopal improving insulin sensitivity and reducing postprandial insulin levels, particularly in individuals with type 2 diabetes or metabolic syndrome. Broiled nopal stems produced approximately 50% reductions in serum insulin in diabetic patients at 180 minutes in clinical trials. A 2-month RCT showed reduced insulin levels after glucose tolerance testing in metabolic syndrome subjects. The mechanism likely involves fiber-mediated slowing of glucose absorption and possible direct effects on insulin signaling.

  • Liver DetoxScientific

    Animal studies show nopal consumption significantly attenuates hepatic steatosis and oxidative stress in obese rats, reducing hepatic triglycerides by approximately 50% and decreasing liver injury biomarkers (ALT, AST). Nopal modulates hepatic lipid metabolism genes and improves liver insulin signaling. A 2023 PMC review of Opuntia's effects on liver health confirmed positive preclinical evidence across multiple Opuntia species. Human evidence for hepatoprotective effects is limited but mechanistically grounded.

  • Several human RCTs have specifically studied nopal in subjects with metabolic syndrome, showing improvements in glucose, triglycerides, C-reactive protein, body weight, BMI, and waist circumference. A 6-week RCT improved HDL and LDL in women with metabolic syndrome. A 2-month RCT with a nopal-containing formula reduced multiple cardiometabolic risk factors. Evidence quality is moderate, primarily from small to medium trials.

  • TriglyceridesScientific

    Human trials and meta-analyses show nopal supplementation reduces serum triglycerides in individuals with metabolic syndrome and dyslipidemia. A 2-month RCT (N=67) with a nopal-containing formula in metabolic syndrome subjects showed significant triglyceride reductions. A 2023 meta-analysis (N=1670) of ancestral Mexican foods reported significant triglyceride reductions. Short-term juice supplementation has also produced decreases in triglycerides.

  • Burns and ScaldsTraditional

    Nopal pad pulp has a long and geographically widespread traditional use as a topical treatment for burns and scalds. Preclinical research confirms that Opuntia ficus-indica seed oil improves healing of laser-induced skin burns in animal models. No controlled human clinical trials for burns specifically have been identified.

  • ColitisTraditional

    Nopal and related Opuntia cacti have traditional use for colitis and intestinal inflammation in Mexican and sub-Saharan ethnomedicine. Preclinical evidence from a rodent DNBS-induced colitis model (using Nopalea cochenillifera, a related Opuntia genus cactus) showed significant reductions in IL-1β, TNF-α, NF-κB activation, and macroscopic colon damage. A promising role in inflammatory bowel disease and colitis has been noted in reviews. No human clinical trials have been identified.

  • DiarrheaTraditional

    Nopal is used in traditional medicine in sub-Saharan Africa and Mexico as an antidiarrheal agent. It is listed in traditional pharmacopeias for diarrhea and dysentery. Nopal's fiber content, including mucilage, is biologically plausible for stool normalization. No controlled human trials for diarrhea as a specific endpoint have been identified.

  • GastritisTraditional

    Nopal has documented traditional use for gastritis, stomachache, and gastrointestinal inflammation across Mexican, sub-Saharan, and other ethnopharmacological traditions. Preclinical mechanisms involving mucilage coating of gastric mucosa and anti-inflammatory polyphenols provide biological plausibility. No controlled human trials specifically addressing gastritis have been identified.

  • HemorrhoidsTraditional

    Nopal flowers have documented traditional use as an oral anti-hemorrhoid medication in sub-Saharan traditional medicine. No human clinical trial evidence for nopal in hemorrhoid treatment has been identified. The anti-inflammatory and fiber-normalizing properties of nopal provide biological plausibility.

  • UlcersTraditional

    Nopal cladodes and mucilage have longstanding traditional use for gastric ulcer protection in Mexican, sub-Saharan, and Mediterranean ethnomedicine. Molecular evidence suggests nopal mucilage monosaccharides interact with gastric mucosal membrane phospholipids to support healing of chronic gastric mucosal damage. Opuntia ficus-indica seed oil demonstrated gastroprotective and ulcer-healing activity in a rodent experimental model. No controlled human trials on ulcers have been identified.

  • Wound HealingTraditional

    The pulp of nopal pads has traditional use across many cultures as a poultice for wounds, burns, cuts, and fractures. A PMC study confirmed Opuntia ficus-indica seed oil improves healing of laser-induced skin burns and full-thickness wounds in animal models. Traditional use is extensive and well-documented in ethnopharmacological literature. Human clinical trials are lacking.

Body Systems

Body systems that Nopal may help support.

  • No body systems available.
Join our newsletter

Stay informed. Stay healthy.

Get expert supplement tips, exclusive discounts, and product recommendations delivered to your inbox